About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Herren Drugs Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 125.00 cr and a paid-up capital of Rs 48.70 cr.
The Corporate has already closed loans amounting to ₹5,501.38 cr, and has no open charges as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mylan Laboratories Limited India are Sarada Bhagawati as Cfo and Nagaraj Bodige as Company Secretary. Mohit Saraf, Rajiv Malik, Sarada Bhagawati, and Two other members serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24231TG1984PLC005146 |
| Company No. | 005146 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 29 Nov 1984 |
| Date of AGM | 31 Jul 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Products or Services related to Mylan Laboratories Limited
HIV Drugs
Antipyretic Medication
Tenofovir Tablet
Anti Infective Agent
Financials of Mylan Laboratories Limited
Mylan Laboratories Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.72% decrease. The company also saw a substantial fall in profitability, with a 25.28% decrease in profit. The company's net worth moved up by a moderate rise of 4.07%.
Corporate Structure
Unlock access to Mylan Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Mylan Laboratories Limited
Unlock and access historical data on people associated with Mylan Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
SB
Sarada Bhagawati
CFOAppointment Date: 01-Nov-2014
Status: Current
NB
Nagaraj Bodige Company SecretaryAppointment Date: 25-Jul-2011
Status: Current
Board Members(5)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 11 Jun 2013 | ₹170.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 27 Nov 2012 | ₹40.00 Cr | Satisfied |
Export - Import Bank Of India Creation Date: 08 Oct 2012 | ₹150.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mylan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Tianish Laboratories Private Limited
Active
1 year 5 months Mohit Saraf and Sarada Bhagawati are mutual person
Recent activity within the organization
Director Appointment
Arvind Shankar Kanda was appointed as a Additional Director was appointed as a Additional Director on 02 Apr 2024 & has been associated with this company since 5 months 20 days .
02 Apr 2024Director Appointment
Akshay Nanda was appointed as a Additional Director was appointed as a Additional Director on 11 Mar 2024 & has been associated with this company since 6 months 12 days .
11 Mar 2024Annual General Meeting
Mylan Laboratories Limited last Annual general meeting of members was held on 31 Jul 2023 as per latest MCA records.
31 Jul 2023Balance Sheet
Mylan Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Mohit Saraf was appointed as a Director was appointed as a Director on 30 Mar 2015 & has been associated with this company since 9 years 5 months .
30 Mar 2015
Recent News, Updates & Announcement
Indias Biocon raises 129mln from Kotak to fund biosimilars deal.Biocon Biologics completed the 334billion acquisition of USbased Viatriss biosimilars business in late Novembernbsp.
Zawya 22 Feb 2023
- European Medicines Agency Accepts Marketing Authorization Applications for Mylan and Biocons Proposed Biosimilars Trastuzumab and Pegfilgrastim.
PRNewswire Mylan NV NASDAQ TASE MYL and Biocon Ltd BSE code 532523 NSE BIOCON today announced that the European Medicines Agency EMA has.
PR Newswire 30 Nov 2017
- Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy.
Fiercepharma 20 Nov 2017
Frequently asked questions
What is the Incorporation or founding date of Mylan Laboratories Limited?
